Hainan Poly Pharm Co Ltd banner
H

Hainan Poly Pharm Co Ltd
SZSE:300630

Watchlist Manager
Hainan Poly Pharm Co Ltd
SZSE:300630
Watchlist
Price: 0.89 CNY Market Closed
Market Cap: ¥68.4m

Profitability Summary

Hainan Poly Pharm Co Ltd's profitability score is 44/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

44 / 100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

44 / 100
Profitability
Score
44 / 100
Profitability
Score

Margins

Earnings Waterfall
Hainan Poly Pharm Co Ltd

Margins Comparison
Hainan Poly Pharm Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Hainan Poly Pharm Co Ltd
SZSE:300630
68.4m CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
837.7B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
583.9B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
228B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
292.3B USD
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
228.6B CHF
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
157.9B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
120.2B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Hainan Poly Pharm Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Hainan Poly Pharm Co Ltd
SZSE:300630
68.4m CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
837.7B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
583.9B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
228B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
292.3B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
228.6B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
157.9B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
120.2B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Hainan Poly Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett